A Phase IIa Study With Escalating Dose of MS1819-SD
A Multicentre Open-label Phase IIa Study With Escalating Dose of MS1819- SD, to Investigate the Efficacy and Safety of a Yarrowia Lipolytica Lipase Preparation for the Compensation of Exocrine Pancreatic Insufficiency Caused by Chronic Pancreatitis and/or Distal Pancreatectomy A Multicentre Open-label Phase IIa Study With Escalating Dose of MS1819- SD, to Investigate the Effi ...
Safety and preliminary clinical activity of Yarrowia lipolytica lipase (MS1819) in patients with malabsorption syndrome due to exocrine pancreatic insufficiency resulting from chronic pancreatitis Safety and preliminary clinical activity of Yarrowia lipolytica lipase(MS1819) in patients with mala ...
Safety and preliminary clinical activity of Yarrowia lipolytica lipase (MS1819) in patients with malabsorption syndrome due to exocrine pancreatic insufficiency resulting from chronic pancreatitis Safety and preliminary clinical activity of Yarrowia lipolytica lipase(MS1819) in patients with mala ...